Literature DB >> 8251332

Genetically engineered kidneys.

A S Woolf1, L G Fine.   

Abstract

We review the available methods of creating genetically engineered kidneys. These include transgenic technology to introduce novel genes or delete existing genes and methods of gene transfer into the post-natal or adult kidney. The use of such technology has provided insights into renal development and growth and created new animal models of human diseases. Although some of these techniques are of potential use for introducing therapeutically useful gene products into the diseased kidney, many problems remain to be solved before this aim is attained.

Entities:  

Mesh:

Year:  1993        PMID: 8251332     DOI: 10.1007/bf00852565

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  Autosomal dominant polycystic kidney disease. Report of a Meeting of Physicians and Scientists, University College and Middlesex School of Medicine, London.

Authors: 
Journal:  Lancet       Date:  1992-05-09       Impact factor: 79.321

2.  Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40.

Authors:  K MacKay; L J Striker; C A Pinkert; R L Brinster; G E Striker
Journal:  Kidney Int       Date:  1987-12       Impact factor: 10.612

3.  Gene transfer into the mammalian kidney: direct retrovirus-transduction of regenerating tubular epithelial cells.

Authors:  R J Bosch; A S Woolf; L G Fine
Journal:  Exp Nephrol       Date:  1993 Jan-Feb

4.  Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene.

Authors:  J J Mullins; J Peters; D Ganten
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

5.  Gene transfer into the mammalian kidney: microtransplantation of retrovirus-transduced metanephric tissue.

Authors:  A S Woolf; R J Bosch; L G Fine
Journal:  Exp Nephrol       Date:  1993 Jan-Feb

6.  Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.

Authors:  R Scharfmann; J H Axelrod; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

7.  Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1.

Authors:  T Doi; L J Striker; C Quaife; F G Conti; R Palmiter; R Behringer; R Brinster; G E Striker
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

Review 8.  Nephrogenesis and the development of renal disease.

Authors:  J B Bard; A S Woolf
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992

9.  Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system.

Authors:  K F Lee; E Li; L J Huber; S C Landis; A H Sharpe; M V Chao; R Jaenisch
Journal:  Cell       Date:  1992-05-29       Impact factor: 41.582

10.  Metanephric mesenchyme contains multipotent stem cells whose fate is restricted after induction.

Authors:  D Herzlinger; C Koseki; T Mikawa; Q al-Awqati
Journal:  Development       Date:  1992-03       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.